RAC to finally relax gene therapy oversight

被引：0
|
作者：
Asher Mullard
机构：
来源：
Nature Biotechnology | 2014年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：858 / 858
相关论文
共 50 条
  • [21] Public oversight is necessary if human gene therapy is to progress
    Zallen, DT
    HUMAN GENE THERAPY, 1996, 7 (07) : 795 - 797
  • [22] Oversight and monitoring of clinical research with gene therapy in Australia
    Trent, RJA
    MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (09) : 441 - 442
  • [23] The Next Phase of Human Gene-Therapy Oversight
    Hurley, Elisa A.
    Hull, Darby
    Shriver, Sharon P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04): : 401 - 402
  • [24] Regulatory Oversight of Cell and Gene Therapy Products in Canada
    Ridgway, Anthony
    Agbanyo, Francisca
    Wang, Jian
    Rosu-Myles, Michael
    REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 49 - 71
  • [25] Is it time to reform oversight of clinical gene therapy in the EU?
    Kenter, Marcel J. H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (01) : 8 - 10
  • [26] ORGANIZATION OF RESEARCH - THE RAC, GENE-THERAPY
    KLEIN, M
    NATURE MEDICINE, 1995, 1 (06) : 497 - 498
  • [27] Gene therapy - Varmus proposes to scrap the RAC
    Marshall, E
    SCIENCE, 1996, 272 (5264) : 945 - 945
  • [28] RAC DEFERS GENE-THERAPY APPROVAL
    JENKS, S
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) : 13 - 14
  • [29] RAC ADVANCES EXVIVO GENE-THERAPY
    BLUESTONE, M
    BIO-TECHNOLOGY, 1992, 10 (04): : 368 - 368
  • [30] RAC OKAYS INVIVO GENE-THERAPY
    EDGINGTON, SM
    BIO-TECHNOLOGY, 1992, 10 (04): : 369 - 369
12345